Cellular transplantation for the treatment of non-ischaemic dilated cardiomyopathies

European Heart Journal, Supplement

Volumn 10, Issue K, 2008, Pages

  Guarita Souza, Luiz César ^a   Teixeira De Carvalho, Katherine Athayde ^a   Francisco, Júlio César ^a   Simeoni, Rossana ^a   Faria Neto, José Rocha ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Bone marrow stromal cell; Cardiomyopathies; Skeletal myoblast cell; Transplantation

Indexed keywords

ARTICLE; CELL TRANSPLANTATION; CONGESTIVE CARDIOMYOPATHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 77949366924     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sun045     Document Type: Article

References (29)

1. Carraway EA, Rayburn BK. Device therapy for remodeling in congestive heart failure. Curr Heart Fail Rep 2007;4:53-58.
2. Guarita-Souza LC, Carvalho KA, Rebelatto C, Senegaglia A, Hansen P, Furuta M, Miyague N, Francisco JC, Olandoski M, Faria-Neto JR, Oliveira SA, Brofman PR. Cell transplantation: differential effects of myoblasts and mesenchymal stem cells. Int J Cardiol 2006;111: 423-429.
3. Kajstura J, Leri A, Finato N, Loreto C, Beltrami C, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998;95:8801-8805.
4. Ghostine S, Carrion C, Souza LC et al. Long term of myoblast transplantation on regional structure and function after myocardium infarction. Circulation 2002;106(Suppl. l):l-131-l-136.
5. Scorsin M, Hagège A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, Menasché P. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarct left ventricular function. J Thorac Cardiovasc Surg 2000; 119:1169- 1175.
6. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 1998;4:929-933.
7. Dorfman J, Duong M, Zibaitis A, Pelletier MP, Shum-Tim D, Li C, Chiu RC. Myocardial tissue engineering with autologous myoblast implantation. J Thorac Cardiovasc Surg 1998;116:744-751.
8. Hagege AA, Marolleau JP, Vilquin JT, Alheritiere A, Peyrard S, Duboc D, Abergel E, Messas E, Mousseaux E, Schwartz K, Desnos M, Menasche P. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006;114(Suppl. 1):I108-I113.
9. Eckert P, Schnackerz K. Ischemic tolerance of human skeletal muscle. Ann Plast Surg 1999;26:77-84.
10. Menasché P. Scientific Session of the American Heart Association. Chicago, 2006.
11. Verfailie CM. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol 2002;12:502-508.
12. Deb A, Wang S, Skelding KA, Miller D, Simper D, Caplice NM. Bone marrow-derived cardiomyocytes are present in adult human heart. Circulation 2003;107:1247-1249.
13. Bel A, Messas E, Agbulut O, Richard P, Samuel JL, Bruneval P, Hagège AA, Menasché P. Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution. Circulation 2003;108:247-252.
14. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410:701-705.
15. Wollert K, Meyer G, Lotz J, Lichtenberg SR, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-148.
16. Perin EC, Dohmann HF, Borojevic B, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belém L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vaughn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-2302.
17. Marzullo P. Nuclear imaging after cell implantation. Int J Cardiol 2004;95(Suppl. 1):S53-S54.
18. Souza LC, Carvalho KA, Rebelatto C, Senegaglia A, Furuta M, Miyague N, Hansen P, Francisco JC, Olandowski M, Brofman PR. Combined transplantation of skeletal myoblasts and mesenchymal cells (co-cultivation) in ventricular dysfunction after myocardial infarction. Arq Bras Cardiol 2004;83:294-299, 288-293.
19. Guarita-Souza LC, Carvalho KA, Woitowicz V, Rebelatto C, Senegaglia A, Hansen P, Miyague N, Francisco JC, Olandoski M, Faria-Neto JR, Brofman P. Simultaneous autologous transplantation of cocultured mesenchymal stem cells and skeletal myoblasts improves ventricular function in a murine model of Chagas disease. Circulation 2006;114(Suppl. 1):I120-I124.
20. Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y, Fujii T, Uematsu M, Ohgushi H, Yamagishi M, Tokudome T, Mori H, Miyatake K, Kitamura S. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005;112:1128-1135.
21. Werner L, Deutsch V, Barshack I, Miller H, Keren G, George J. Transfer of endothelial progenitor cells improves myocardial performance in rats with dilated cardiomyopathy induced following experimental myocarditis. J Mol Cell Cardiol 2005;39:691-697.
22. Pouly J, Hagege AA, Vilquin JT, Bissery A, Rouche A, Bruneval P, Duboc D, Desnos M, Fiszman M, Fromes Y, Menasche P. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Circulation 2004;110:1626-1631.
23. Soares MB, Lima RS, Rocha LL, Takyia CM, Pontes-de-Carvalho L, de Carvalho AC, Ribeiro-dos-Santos R. Transplanted bone marrow cells repair heart tissue and reduce myocarditis in chronic chagasic mice. Am J Pathol 2004;164:441-447.
24. Ishida M, Tomita S, Nakatani T, Fukuhara S, Hamamoto M, Nagaya N, Ohtsu Y, Suga M, Yutani C, Yagihara T, Yamada K, Kitamura S. Bone marrow mononuclear cell transplantation had bene.cial effects on doxorubicin-induced cardiomyopathy. J Heart Lung Transplant 2004;23:436-445.
25. Lago N, Trainini J, Christen A, Guevara E, Mouras J, Alvarez M, Masoli O, Barisani J. Mononuclear bone marrow stem cells implant as an alternative treatment in non-ischemic dilated cardiomyopathy. J Am Coll Cardiol 2006;47(4 Suppl. A):1A-384A.
26. Ghodsizad A, Ruhparwar A, Marktanner R, Borowski A, Mohammad Hasani MR, Poll L, Vshivkov I, Stoldt V, Voelkel T, Piechaczek C, Burchardt ER, Stockschlaeder M, Sucker C, Gams E, Klein HM. Autologous transplantation of CD133+ BM-derived stem cells as a therapeutic option for dilatative cardiomyopathy. Cytotherapy 2006;8: 308-310.
27. Kalil RA, Ott D, Sant'Anna R, Dias E, Marques-Pereira JP, Delgado-Cañedo A, Nardi NB, Sant'Anna JR, Prates PR, Nesralla I. Autologous transplantation of bone marrow mononuclear stem cells by minithoracotomy in dilated cardiomyopathy: technique and early results. Sao Paulo Med J 2008;126:75-81.
28. Stolf NA, Higushi L, Bocchi E, Bellotti G, Auler JO, Uip D, Amato Neto V, Pileggi F, Jatene AD. Heart transplantation in patients with Chagas' disease cardiomyopathy. J Heart Transplant 1987;6: 307-312.
29. Vilas-Boas F, Feitosa GS, Soares MB, Mota A, Pinho-Filho JA, Almeida AJ, Andrade MV, Carvalho HG, Dourado-Oliveira A, Ribeiro-dos-Santos R. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease. Arq Bras Cardiol 2006;87:159-156.